In some embodiments, the pharmaceutical formulations or compositions described herein are used in combination with (e.g., implantation, short-term use, long-term use, or removal of) implants (e.g., cochlear implants)
In todays era of Risk-Based Monitoring (RBM), its not about checking everything Its about focusing on what truly matters
Risk Groups and Risk Factors Individuals with the diseases already described, primarily involving tumors of the liver, may develop hypercobalaminemia
and improvement of nonmotor features such as cognitive impairment, depression, fatigue, and sleep disorders
215 Cyst(e)inase degrades extracellular cysteine and cystine and leads to decreased levels of intracellular cysteine and glutathione, which profoundly affects the redox potential of cancer cells 216 and counteracts the essential role of cysteine in cancer cells